Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 1Neoplasms 1Leiomyosarcoma 1

Interventions

Doxorubicin 13Gemcitabine 10Ifosfamide 9Trabectedin 7Radiotherapy 7Docetaxel 5Dacarbazine 5pazopanib 3Sunitinib 3Sorafenib 3Nivolumab 3Filgrastim 3pembrolizumab 2pegfilgrastim 2liposomal doxorubicin 2eribulin 2cixutumumab 2belinostat 2Radiotherapy, Conformal 2Imatinib Mesylate 2Chemotherapy, Adjuvant 2Bevacizumab 2tremelimumab 1temsirolimus 1soblidotin 1selinexor 1sargramostim 1saracatinib 1rubitecan 1romidepsin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leiomyosarcoma × PTC596 × Clear all
NCT03761095 2024-03-15

A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

PTC Therapeutics

Phase 1 Completed
41 enrolled
Sarcoma

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡